OPTIMIZATION-BY-DESIGN
LIVE

Serial Number

99087625

Owner

Andelyn Biosciences, Inc.

Attorney

Ajay Jagtiani

Filing Date

Mar 17, 2025

Add to watchlist:

No watchlists yet
View on USPTO

OPTIMIZATION-BY-DESIGN Trademark

Serial Number: 99087625

OPTIMIZATION-BY-DESIGN is a trademark filed by Andelyn Biosciences, Inc. on March 17, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Andelyn Biosciences, Inc. (14 trademarks)

1180 Arthur E. Adams Dr.
Columbus, OH 43221

Entity Type: 03

Trademark Details

Filing Date

March 17, 2025

Registration Date

Not Registered

Published for Opposition

February 3, 2026

Goods & Services

Business collaboration services, namely, providing a national computer-based networking web site for medical researchers to collaborate across disciplines to contract for development and manufacture of gene therapy and pharmaceutical products; all the foregoing not relating to restorative components for dental implants and dental restoration systems

Manufacturing services for others in the field of pharmaceuticals, biopharmaceuticals, health care products and medical products; treatment of materials, namely, pharmaceutical and chemical products and their components used in the manufacture of pharmaceuticals and biopharmaceuticals; manufacture of pharmaceuticals and biopharmaceuticals to order and/or specification of others; contract manufacturing of pharmaceuticals, cells and gene therapy reagents; all the foregoing not relating to restorative components for dental implants and dental restoration systems

Product development for others relating to pharmaceuticals, biopharmaceuticals; scientific and technological consulting services, namely, research and design in the field of pharmaceutical industry; product testing and research in the field of pharmaceuticals, biopharmaceuticals; industrial research in the field of pharmaceuticals, biopharmaceuticals; pharmaceutical and biopharmaceutical drug development services; pharmaceutical and biopharmaceutical research and development; product development consultation; product research services, namely, providing analytical product testing, biosafety product testing and laboratory services for the production of pharmaceutical preparations for others; scientific and technical product development consulting for the pharmaceutical industry; research services in the field of pharmaceuticals; custom design and development of chemical reagents and biochemical assays; providing online non-downloadable computer software platform for users to access an integrated set of scientific and technical software capabilities, namely, software for enterprise resource planning, quality management, document management and sharing, learning management, laboratory information management, computerized maintenance management and data capture, built with quality and security in mind to deliver value to customers through the productization of data, adoption of advanced technologies, and focusing on collaborative total experience; all the foregoing not relating to restorative components for dental implants and dental restoration systems

Pharmaceutical preparations, biological preparations, and gene therapy products, namely, genetically engineered tissues for transplant purposes for medical or pharmaceutical purposes, namely, viral vector vaccines, and nucleic-acids delivery products for use in the treatment of genetic diseases and disorders; all the foregoing not relating to restorative components for dental implants and dental restoration systems

Filing History

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 3, 2026 NPUB
PUBLISHED FOR OPPOSITION
Feb 3, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 28, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 8, 2026 CNSA
EXAMINER'S AMENDMENT ENTERED
Jan 8, 2026 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 8, 2026 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 8, 2026 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 8, 2026 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 6, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 6, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 6, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 23, 2025 GNRN
NON-FINAL ACTION E-MAILED
Aug 23, 2025 GNRT
NON-FINAL ACTION WRITTEN
Aug 23, 2025 CNRT
ASSIGNED TO EXAMINER
Aug 16, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 4, 2025 NWOS
APPLICATION FILING RECEIPT MAILED
Mar 17, 2025 MAFR
NEW APPLICATION ENTERED
Mar 17, 2025 NWAP